Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)

This study is currently recruiting participants.
Verified June 2012 by Shanghai Jiao Tong University School of Medicine
Sponsor:
Information provided by (Responsible Party):
Xiao-Ying Li, Shanghai Jiao Tong University School of Medicine
ClinicalTrials.gov Identifier:
NCT01418027
First received: August 15, 2011
Last updated: June 6, 2012
Last verified: June 2012
  Purpose

The prevalence of NAFLD is 50-70% in obese. A decrease of calorie intake and increase of physical activity is recommended as an effective approach for NAFLD. The intensive physical activities are usually adopted. However,the effect of moderate physical activities on NAFLD has not been determined. We hypothesized that intensive induced conventional exercise would improve NAFLD better than the lifestyle counseling alone did.


Condition Intervention Phase
Non-alcoholic Fatty Liver Disease (NAFLD)
Other: Intensive exercise
Other: Regular exercise
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Combined Intensive and Conventional Exercise Intervention of Nonalcoholic Fatty Liver Disease

Resource links provided by NLM:


Further study details as provided by Shanghai Jiao Tong University School of Medicine:

Primary Outcome Measures:
  • The change of intrahepatic triglyceride contents [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The change of rate of metabolic syndrome [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 180
Study Start Date: August 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intensive exercise
The subjects receive an intensive exercise for 6 months and a consequent regular exercise for another 6 months.
Other: Intensive exercise
Subects conduct an aerobic exercise at 65-80% maximum oxygen consumption for 30 minutes each day, five days a week, totally for 6 months.Subsequently, moderate physical activity(3.0-6.0 MET h) at 150 min/wk for 6 months.
No Intervention: Lifestyle counseling
Subjects receive a general lifestyle counseling for 12 months
Experimental: Regular exercise
Subjects receive regular exercise for 12 months
Other: Regular exercise
Subjects receive moderate physical activity(3.0-6.0 MET h)per day for 12 months

  Eligibility

Ages Eligible for Study:   40 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  1. Subjects with NAFLD determined by MRS ;
  2. Age 40-65 years old;
  3. Waist circumference> 90cm for men and > 85cm for wemen.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01418027

Contacts
Contact: Ma Zhi-Min, MD 86-592-2137558 mazhimin01@sina.com
Contact: Zhang Hui-Jie, MD 86-592-2137558 huijiezhang2005@126.com

Locations
China, Fu Jian
The First Hospital Affiliated to Xiamen University Recruiting
Xiamen, Fu Jian, China
Contact: Ma Zhi-Min, MD     86-592-2137558     mazhimin01@sina.com    
Contact: Zhang Hui-Jie, MD     86-592-2137558     huijiezhang2005@126.com    
Sponsors and Collaborators
Shanghai Jiao Tong University School of Medicine
Investigators
Principal Investigator: Xiaoying Li, MD,PhD Shanghai Jiao Tong University School of Medicine
  More Information

No publications provided

Responsible Party: Xiao-Ying Li, Professor, Shanghai Jiao Tong University School of Medicine
ClinicalTrials.gov Identifier: NCT01418027     History of Changes
Other Study ID Numbers: CCEMD011
Study First Received: August 15, 2011
Last Updated: June 6, 2012
Health Authority: China: Food and Drug Administration

Keywords provided by Shanghai Jiao Tong University School of Medicine:
NAFLD
exercise
hepatic triglycerides

Additional relevant MeSH terms:
Fatty Liver
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 19, 2013